A
Alethio Therapeutics develops novel medicines focused on chronic blood cancer. The company's work centers on innovating therapeutic approaches to improve patient outcomes. Their goal is to extend and enhance the lives of individuals living with these long-term hematologic malignancies.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Alethio Therapeutics develops novel medicines focused on chronic blood cancer. The company's work centers on innovating therapeutic approaches to improve patient outcomes. Their goal is to extend and enhance the lives of individuals living with these long-term hematologic malignancies.